Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Deleterious effect of lipoprotein(a) ≥180 nmol/L possibly mitigated by high-impact LDL-cholesterol-lowering therapy
Read More »Lipoprotein(a) Levels Tied to Increased Risk of Recurrent Atherosclerotic CVD Events
Persistent, New Mucus Plugs Associated With Faster Decline in FEV1 in COPD
The steepest decrease in FEV1 seen for those with persistently positive mucus plugs who resume smoking
Read More »Combinations of Chronic, Physical Illnesses Up the Risk of Subsequent Depression
In the highest-risk groups, roughly one in 12 people developed depression over the next 10 years
Read More »Florida-Grown Cucumbers Behind Salmonella Outbreak, CDC Warns
By I. Edwards HealthDay ReporterWEDNESDAY, May 21, 2025 (HealthDay News) — Health officials are investigating a salmonella outbreak tied to cucumbers grown in Florida.At least 26 people across 15 states have gotten sick, and nine people have been hospitalized, the U.S. Food and Drug Administration (FDA) said May 19, the …
Read More »Nebraska First State to Ban Soda, Energy Drinks From SNAP Program
By I. Edwards HealthDay ReporterWEDNESDAY, May 21, 2025 (HealthDay News) — Nebraska is the first state to get federal approval to ban the purchase of soda and energy drinks under the Supplemental Nutrition Assistance Program (SNAP), also known as food stamps.The change, announced Monday by U.S. Agriculture Secretary Brooke Rollins, …
Read More »FDA Limits COVID-19 Boosters to Seniors, Other High-Risk Groups
By I. Edwards HealthDay ReporterWEDNESDAY, May 21, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has decided that only seniors and people at high risk should get the latest COVID-19 booster shots this fall.The new framework, announced Tuesday, says adults 65 and older, and people with certain …
Read More »FDA Approves Zynyz as First-Line Treatment for Advanced Anal Cancer
The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapy
Read More »No Increase Seen in Neurodevelopmental Disorders With Prenatal Triptan Use
No significantly increased risk seen with exposure to different triptan intensities and duration, alone or in combination with other preventive medications
Read More »Residual Inflammation Seen in One-Third of Patients With Psoriasis on Biologics
Residual inflammation significantly linked to higher BMI, metabolic dysfunction-associated steatotic liver disease, baseline systemic inflammation
Read More »PREVENT Risk Score Accurately IDs People With Coronary Artery Calcium
Risk discrimination of incident myocardial infarction events improved by adding coronary artery calcium to PREDICT risk
Read More »